Sale to Linden Capital Partners

Healthcare
Sale to Linden Capital Partners

Summary

Baird served as a financial advisor to Collagen Matrix, Inc. on this transaction

About

Collagen Matrix, Inc. (“Collagen Matrix” or the “Company”), a portfolio company of Metalmark Capital (“Metalmark”), recently announced its sale to Linden Capital Partners (“Linden”). Terms of the transaction were not disclosed.

Collagen Matrix is a developer and manufacturer of collagen-based medical products used for tissue and bone repair and regeneration. Founded in 1997, Collagen Matrix develops proprietary products that are sold to OEM customers on either a contract or private label basis across orthopedic, sports medicine, dental, and neurosurgery end markets. The Company also offers partnership opportunities including distribution, contract product development, and contract manufacturing services. Collagen Matrix is headquartered in Oakland, New Jersey.

Metalmark Capital is a leading private equity firm that seeks to build long-term value through active and collaborative partnerships with business owners, founders, and executives. The firm focuses its investment activity in healthcare, industrials and agribusiness. Metalmark Capital manages funds with $3.7 billion in aggregate capital commitments. Metalmark is headquartered in New York, New York.

Linden is a private equity firm focused exclusively on investing in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms across the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Linden is headquartered in Chicago, Illinois.
CONTACT US TO LEARN MORE
Healthcare
Sale to Linden Capital Partners
Date
August 2019
Company
Collagen Matrix, Inc.
Transaction
M&A
Sectors
Healthcare
Target Location
North America
Acquiror Location
North America

Share